U.S. flag

An official website of the United States government

NC_000019.9:g.(?_39066549)_(39078060_?)del AND RYR1-Related Disorders

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Sep 9, 2021
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001377916.5

Allele description

NC_000019.9:g.(?_39066549)_(39078060_?)del

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
19q13.2
Genomic location:
Chr19: 39066549 - 39078060 (on Assembly GRCh37)
Preferred name:
NC_000019.9:g.(?_39066549)_(39078060_?)del
HGVS:
NC_000019.9:g.(?_39066549)_(39078060_?)del

Condition(s)

Name:
RYR1-Related Disorders
Identifiers:
MedGen: CN239331

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001575367Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Sep 9, 2021)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Central core disease due to recessive mutations in RYR1 gene: is it more common than described?

Kossugue PM, Paim JF, Navarro MM, Silva HC, Pavanello RC, Gurgel-Giannetti J, Zatz M, Vainzof M.

Muscle Nerve. 2007 May;35(5):670-4.

PubMed [citation]
PMID:
17226826

Ryanodine myopathies without central cores--clinical, histopathologic, and genetic description of three cases.

Rocha J, Taipa R, Melo Pires M, Oliveira J, Santos R, Santos M.

Pediatr Neurol. 2014 Aug;51(2):275-8. doi: 10.1016/j.pediatrneurol.2014.04.024. Epub 2014 Apr 28.

PubMed [citation]
PMID:
24950660
See all PubMed Citations (6)

Details of each submission

From Invitae, SCV001575367.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

This variant is a gross deletion of the genomic region encompassing exon(s) 97-106 of the RYR1 gene, which includes the termination codon. This deletion extends beyond the assayed region for this gene and therefore may encompass additional genes. While this deletion is not anticipated to lead to nonsense mediated decay, it is expected to alter mRNA translation or result in a truncated protein product. This variant has not been reported in the literature in individuals affected with RYR1-related conditions. This variant disrupts the p.Ala4846 amino acid residue in RYR1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17226826, 24950660, 26275793, 29096039, 30611313; Invitae). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 13, 2023